Published in JAMA on May 11, 1994
beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med (2005) 2.45
Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev (2008) 2.38
Randomised placebo controlled trial of beta agonist dose reduction in asthma. Thorax (1999) 1.68
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev (2010) 1.52
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
A word of caution regarding a new long-acting bronchodilator. JAMA (1994) 1.41
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev (2010) 1.16
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children. Cochrane Database Syst Rev (2009) 1.14
Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax (1998) 1.11
Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J Allergy Clin Immunol (2006) 1.02
Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials. BMC Med (2007) 0.96
Effect of regular terbutaline on the airway response to inhaled budesonide. Thorax (1996) 0.86
Salmeterol xinafoate vs albuterol in asthma: was race a factor? JAMA (1994) 0.85
Outpatient treatment of adult asthma. West J Med (1995) 0.78
Asthma therapy--future promise and current practice. West J Med (1995) 0.75
Clinical management of asthma in the 1990s. Current therapy and new directions. Drugs (1996) 0.75
[Long-acting beta(2)-adrenoceptor agonists for asthma and COPD]. Med Klin (Munich) (1997) 0.75
Laminin--a glycoprotein from basement membranes. J Biol Chem (1979) 12.49
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) (1986) 6.86
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. Lab Invest (1980) 3.64
Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc Natl Acad Sci U S A (1980) 3.57
Chicken soup inhibits neutrophil chemotaxis in vitro. Chest (2000) 3.48
Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem (1980) 3.28
Enrichment for murine keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci U S A (2000) 3.12
Epithelial stem cells in vivo. J Cell Sci Suppl (1988) 2.99
Antigens on mouse and rat lymphocytes recognized by rabbit antiserum against rat brain: the quantitative analysis of a xenogeneic antiserum. Eur J Immunol (1975) 2.92
Analysis in deoxycholate of three antigenic specificities associated with the rat Thy-1 molecule. Eur J Immunol (1975) 2.44
Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial. Ann Intern Med (1990) 2.40
New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet (1980) 2.35
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Psychiatric illness in family practice. J Clin Psychiatry (1980) 2.29
Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry (1986) 2.28
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest (1981) 2.20
The likelihood of homoploid hybrid speciation. Heredity (Edinb) (2000) 2.15
Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med (1997) 2.12
Antibodies to laminin in Chagas' disease. J Exp Med (1982) 2.11
Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone. Am J Respir Crit Care Med (2001) 2.05
Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents. J Fam Pract (1994) 1.95
Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members. N Engl J Med (1986) 1.90
Estimation of the amount and tissue distribution of rat Thy-1.1 antigen. Eur J Immunol (1974) 1.88
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest (1986) 1.82
Neutrophil chemotactic factors in bacterial pneumonia. Chest (1989) 1.69
Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med (1990) 1.67
Pulmonary macrophages can stimulate cell growth of bovine bronchial epithelial cells. Am J Respir Cell Mol Biol (1990) 1.66
Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts. Mod Pathol (1999) 1.64
Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis (1984) 1.64
Role of fibronectin as a growth factor for fibroblasts. J Cell Biol (1983) 1.64
Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. J Clin Invest (1984) 1.61
Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis (1989) 1.58
Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am Rev Respir Dis (1987) 1.57
Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA (1997) 1.56
Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol (2001) 1.55
Anterior segment ischemia following vertical muscle transposition and botulinum toxin injection. Arch Ophthalmol (1990) 1.54
Inferior rectus recession--an effective procedure? Br J Ophthalmol (1997) 1.51
Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis (1991) 1.49
Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma. Chest (1999) 1.48
Evidence that the centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J Invest Dermatol (1985) 1.47
Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy (1991) 1.44
Coronary artery disease in identical twins. Ann Thorac Surg (1999) 1.44
Diagnosis and management of traumatic aorto-right ventricular fistulas. Ann Thorac Surg (1998) 1.42
Neutrophilic respiratory tract inflammation and peripheral blood neutrophilia after grain sorghum dust extract challenge. Chest (1995) 1.42
Administration errors with a conventional metered dose inhaler versus a novel breath actuated device. Ann Allergy (1993) 1.42
The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Prev Med (1999) 1.42
Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen. Cancer Res (1986) 1.41
Procollagen production and procollagen messenger RNA levels and activity in human lung fibroblasts during periods of rapid and stationary growth. J Biol Chem (1981) 1.41
Bimedial rectus recession using the anchored hang-back technique. Ophthalmic Surg Lasers (1997) 1.40
A simple method of decreasing the morbidity of split-thickness skin graft donor sites. Br J Plast Surg (1999) 1.39
Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med (1991) 1.38
Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia. N Engl J Med (1983) 1.38
Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology (1992) 1.36
Rat thy-1 antigens from thymus and brain: their tissue distribution, purification, and chemical composition. Cold Spring Harb Symp Quant Biol (1977) 1.36
Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia (1999) 1.36
Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes (1999) 1.36
Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Pediatr (1998) 1.32
Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 1.31
Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev Biol Anim (1997) 1.28
Fixation of Thy-1 in nervous tissue for immunohistochemistry: a quantitative assessment of the effect of different fixation conditions upon retention of antigenicity and the cross-linking of Thy-1. J Histochem Cytochem (1983) 1.27
Demonstration of Thy-1 antigen on pluripotent hemopoietic stem cells in the rat. J Exp Med (1978) 1.26
Acetaldehyde-stimulated PKC activity in airway epithelial cells treated with smoke extract from normal and smokeless cigarettes. Proc Soc Exp Biol Med (2000) 1.25
Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience (2002) 1.25
Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature (1996) 1.25
Immunological functions of the pulmonary epithelium. Eur Respir J (1995) 1.22
Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22
Smoke and viral infection cause cilia loss detectable by bronchoalveolar lavage cytology and dynein ELISA. Am J Respir Crit Care Med (1994) 1.21
Hormonal requirements for basement membrane collagen deposition by cultured rat mammary epithelium. Lab Invest (1979) 1.20
A marked disparity between the expression of prion protein and its message by neurones of the CNS. Neuroscience (2002) 1.20
Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Respir Dis (1985) 1.20
A composite CMV-IE enhancer/beta-actin promoter is ubiquitously expressed in mouse cutaneous epithelium. Exp Cell Res (1998) 1.19
Transplanted BM and BM side population cells contribute progeny to the lung and liver in irradiated mice. Cytotherapy (2003) 1.19
Effect of collagen and cell shape on binding of fibronectin to cells. Arch Biochem Biophys (1981) 1.18
Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med (1995) 1.13
Phthalic acid in the deep sea jellyfish Atolla. Nature (1970) 1.13
Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis. Am J Pathol (1985) 1.13
Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci (Lond) (1996) 1.13
Total indoor smoking ban and smoker behavior. Prev Med (1992) 1.12
Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med (1991) 1.12
Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med (1993) 1.12
On the enzymatic activation of NADH. J Biol Chem (2000) 1.11
Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis (1991) 1.11
Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis. Am Rev Respir Dis (1984) 1.11
Kinetics of ligand binding and quaternary conformational change in the homodimeric hemoglobin from Scapharca inaequivalvis. J Biol Chem (1984) 1.11
Association of thy-1 cell surface differentiation antigen with certain connective tissues in vivo. Cell Tissue Res (1980) 1.10
Preparation of collagen substrates for cell attachment: effect of collagen concentration and phosphate buffer. Anal Biochem (1979) 1.09
Nanosecond laser photolysis of aqueous carbon monoxy- and oxyhaemoglobin. Biochim Biophys Acta (1980) 1.08
SPINE bioinformatics and data-management aspects of high-throughput structural biology. Acta Crystallogr D Biol Crystallogr (2006) 1.08
Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol (2001) 1.08
Complement activation by cigarette smoke. Am J Physiol (1991) 1.08
NIH conference. Airway inflammation. Ann Intern Med (1995) 1.08
The use of Prolene as a temporary suspensory material for brow suspension in young children. Eye (Lond) (1994) 1.08
Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann Thorac Surg (2001) 1.07
Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. Cancer Res (1980) 1.07